Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CIEN vs GSK✓SelectedUSD · GSKCIEN vs GSK performance historyLatest closeAs of+0.66%11/18
Stock and ETF performance explorer

CIEN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+492.8%
GSK return
+56.0%
Excess return
+436.8%
Maximum drawdown
-63.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.0%+0.5%
7D-10.0%-3.1%-6.8%-10.2%
30D-22.6%-0.9%-21.7%-22.5%
3M-34.3%-4.2%-30.1%-34.0%
6M-49.2%-1.6%-47.6%-49.1%
YTD+14.0%+2.6%+11.4%+14.6%
1Y+42.5%+6.2%+36.3%+43.2%
All+492.8%+56.0%+436.8%+442.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling